BRIVIACT 25 MG TABLET

brivaracetam
$24.0749per EA
DEA Schedule CV

Strength

25 mg/1

Manufacturer

UCB, Inc.

NDC

50474047009

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

BRIVARACETAM

Approval Type

New Drug (NDA)

FDA Application

NDA205836

On Market Since

5/12/2016

Pharmacological Classes

Epoxide Hydrolase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.7%

1Y

+2.5%

3Y

+9.9%

5Y

+23.6%

All

+31.1%

Generic Alternatives

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.